Clinical Trials Browser

disitamab vedotin × Breast × 90 days × Clear all

NCT05831878 2026-05-13

RC48-ADC in HER2-low Advanced Breast Cancer

Phase NA Recruiting

Advanced Breast Cancer

NCT06157892 2026-05-05

A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

Phase 2 Recruiting

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT06966453 2026-04-21

A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

Phase 1/2 Recruiting

Breast Neoplasms